55 related articles for article (PubMed ID: 37206191)
1. Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases.
Aydin C; Ulas T; Hangul C; Yucel OK; Iltar U; Salim O; Ekinci D; Berker Karauzum S
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):284-291. PubMed ID: 32425379
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal genetically detectable minimal residual disease by fluorescence
Cui J; Yu T; Lv R; Liu J; Fan H; Yan W; Xu J; Du C; Deng S; Sui W; Ho M; Xu Y; Anderson KC; Dong X; Qiu L; An G
Ther Adv Med Oncol; 2024; 16():17588359231221340. PubMed ID: 38249329
[TBL] [Abstract][Full Text] [Related]
3. Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma.
Mansilla C; Soria E; Vallejo M; Valiente A; Perez-Juana A; Zabalza A; Hurtado G; Sala F; Ramírez N
Transl Oncol; 2018 Jun; 11(3):647-652. PubMed ID: 29604510
[TBL] [Abstract][Full Text] [Related]
4. Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications.
Chen M; Jiang J; Hou J
Biomark Res; 2023 May; 11(1):55. PubMed ID: 37259170
[TBL] [Abstract][Full Text] [Related]
5. The quantification of circular RNA 0007841 during induction therapy helps estimate the response and survival benefits to bortezomib-based regimen in multiple myeloma.
Guo Y; Feng X; Wang Z; Zhang R; Zheng K; Xu J; Hu P; Zhang R
Ir J Med Sci; 2024 Feb; 193(1):17-25. PubMed ID: 37336827
[TBL] [Abstract][Full Text] [Related]
6. A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma.
Zhang B; Wang Q; Lin Z; Zheng Z; Zhou S; Zhang T; Zheng D; Chen Z; Zheng S; Zhang Y; Lin X; Dong R; Chen J; Qian H; Hu X; Zhuang Y; Zhang Q; Jin Z; Jiang S; Ma Y
Front Cell Dev Biol; 2023; 11():1198949. PubMed ID: 37333985
[No Abstract] [Full Text] [Related]
7. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
Sawyer JR
Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
9. A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma.
Kalal AA; Arumugam M; Shetty VV; Shetty KP; Krishna R; Shetty RA; Kulkarni NV; Shetty DP
J Taibah Univ Med Sci; 2023 Oct; 18(5):1138-1147. PubMed ID: 37206191
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Implications of Monosomies in Patients With Multiple Myeloma.
Shin SY; Eom HS; Sohn JY; Lee H; Park B; Joo J; Jang JH; Lee MN; Kim JK; Kong SY
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):159-164.e2. PubMed ID: 28089441
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India.
Govindasamy P; Pandurangan P; Tarigopula A; Mani R; R Samuel C
Asian Pac J Cancer Prev; 2019 Jan; 20(1):235-241. PubMed ID: 30678438
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
14. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
Abdallah N; Rajkumar SV; Greipp P; Kapoor P; Gertz MA; Dispenzieri A; Baughn LB; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Go RS; Hwa YL; Fonder A; Hobbs M; Lin Y; Leung N; Kourelis T; Warsame R; Siddiqui M; Lust J; Kyle RA; Bergsagel L; Ketterling R; Kumar SK
Blood Cancer J; 2020 Aug; 10(8):82. PubMed ID: 32782240
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
